Subscribe To
Iq-ai notes positive outcomes from recent pediatric brain tumour studies
IQ-AI Ltd's (LSE:IQAI, OTCQB:IQAIF) wholly-owned subsidiary Imaging Biometrics has noted the outcomes of two pre-clinical ...
June 27, 2023, 5:21 am
Aud/usd: bears pausing but hold grip
Bears are taking a breather after sharp fall in past two days, but remain fully in play, following bearish signals on Friday’s close below 200DMA (0...
June 26, 2023, 2:33 pm
Novo nordisk (nvo) posts upbeat once-weekly insulin icodec data
Novo Nordisk (NVO) announces encouraging new data from its late-stage ONWARDS 1 and 3 studies on once-w...
June 26, 2023, 12:46 pm
Pfizer to discontinue development of obesity drug
Pfizer Inc said on Monday it is discontinuing the development of an experimental obesity and diabetes drug, lotiglipron, due to elevated liver enzymes...
June 26, 2023, 7:03 am
Lexicon announces planned advancement of lx9211 into late-stage development
First late-stage study will be a Phase 2b dose optimization study, with extension to run in parallel with next-stage Phase 3 ...
June 24, 2023, 12:45 am
Why tesla' elon musk and apple's tim cook are investing in india
CSIS Senior Adviser & Chair in U.S.-India Policy studies, spoke with Yahoo Finance's Akiko Fujita about...
June 21, 2023, 5:28 pm
Mersana (mrsn) down on partial ovarian cancer study hold
Mersana's (MRSN) shares decline on partial clinical hold by the FDA on UP-NEXT and UPGRADE-A studies ev...
June 16, 2023, 12:20 pm
Hepion pharmaceuticals to present two posters at easl international liver congress™ 2023
- Preclinical studies demonstrate rencofilstat may protect against NASH/NAFLD, shift the liver transcri...
June 15, 2023, 4:45 pm
Numinus wellness reveals partnership with the multidisciplinary association for psychedelic studies
Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) revealed that it has partnered with the Multidisciplinary Association for Psychedelic ...
June 15, 2023, 8:31 am
Us fda puts mersana therapeutics' ovarian cancer drug studies on partial hold
Mersana Therapeutics Inc said on Thursday the U.S. Food and Drug Administration (FDA) had put a partial clinical hold on its ovarian cancer drug ...
June 15, 2023, 8:03 am
Aud/usd: bulls crack pivotal resistance zone as fed expected to stay on hold
Australian dollar remains bid in Asia / early Europe on Wednesday, underpinned by weaker dollar and rise in Dalian iron ore. Bulls cracked the lower b...
June 14, 2023, 1:49 pm
Can-fite (canf) up on namodenoson progress in pancreatic cancer
Can-Fite's (CANF) shares rise 11.4% as it reveals its plans of submitting an investigational new drug application. The idea is to initiate expansion <...
June 14, 2023, 1:28 pm
Cfos are pivotal esg players
Various studies confirm that there are bottom-line benefits for companies that prioritize environmental...
June 14, 2023, 1:06 pm
Gracell biotechnologies (grcl) surges 62% in a week: here's why
Shares of Gracell (GRCL) increase after it reported positive data from two clinical studies, which eval...
June 14, 2023, 12:58 pm
Nurix therapeutics presents data from studies of its targeted protein degraders in b cell malignancies and initiates expansion of nx-2127 phase 1b trial in diffuse large b cell lymphoma and mantle cel
Initiation of NX-2127 Phase 1b expansion cohort in patients with diffuse large B cell lymphoma (DLBCL) was informed by a rapid and sustained complete ...
June 14, 2023, 11:00 am
Cancer biologics market set to surpass usd 185.0 bn by 2031 driven by increasing cancer prevalence and biotechnology innovations, reveals tmr study
The cancer biologics market North America is witnessing significant revenue opportunities due to considerable clinical ...
June 13, 2023, 10:30 am
Gbp/usd: larger bulls pause ahead of key economic events
Cable pulled back from new one-month high on Monday, as traders collected profits from rally in past three days. Overbought daily ...
June 12, 2023, 2:46 pm
Roche (rhhby) announces positive results from pnh studies
Roche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in the phase III COMMODORE 1 and COMMODORE 2 ...
June 12, 2023, 12:13 pm
Editas (edit) posts upbeat initial data from scd & tdt studies
Editas (EDIT) announces positive preliminary safety and efficacy data from patients treated with its lead drug, EDIT-301, in the RUBY and EdiTHAL
June 12, 2023, 11:13 am
Reasons to retain shockwave medical (swav) in your portfolio
ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies<...
June 6, 2023, 1:45 pm